By mimicking these signals, Zepbound: Decreases appetite and food intake Prolongs feelings of fullness after eating Helps regulate insulin and glucose levels Supports steady, sustained weight loss By targeting both GIP and GLP-1 receptors (instead of GLP-1 alone), Zepbound may provide greater metabolic benefits than medications like Ozempic, Wegovy, or Mounjaro for some patients
Our team walks through every cost option at your free consultation including HSA/FSA payment, manufacturer savings programs, and financing plans
According to a study published in the medical journal Obesity, 44.9% of adolescents who received a weekly dose of semaglutide were no longer considered clinically obese
CARDIOVASCULAR DISEASE There have been no randomized studies that have examined the effect of bile acid sequestrants on cardiovascular end points in subjects with diabetes
A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987-1993) Gastroenterology
The GLP-1 gave me back the ground under my feet, by taking weight off it